ampulla of vater small cell neuroendocrine carcinoma
asbestos-related lung carcinoma
Bartholin gland small cell carcinoma
Benign Carotid Body Paraganglioma
Bladder Small Cell Neuroendocrine Carcinoma
bronchogenic carcinoma +
Carcinoma, Lewis Lung
Cervical Small Cell Carcinoma
colon small cell neuroendocrine carcinoma
Combined Lung Carcinoma +
CORL23
Endometrial Small Cell Carcinoma
esophageal small cell neuroendocrine carcinoma
Gallbladder Small Cell Neuroendocrine Carcinoma
Gastric Small Cell Neuroendocrine Carcinoma
Laryngeal Small Cell Carcinoma
lung carcinoid tumor
lung carcinoma in situ +
Lung Inflammatory Myofibroblastic Tumor
Lung Lymphangioleiomyomatosis
Malignant Jugulotympanic Paraganglioma
NCI-H661
non-small cell lung carcinoma +
Ovarian Small Cell Carcinoma
Pancreatic Small Cell Neuroendocrine Carcinoma
Prostate Small Cell Carcinoma
pulmonary large cell neuroendocrine carcinoma
Salivary Gland Small Cell Carcinoma
small cell lung carcinoma +
Small cell lung cancer (SCLC) is a highly aggressive malignant neoplasm, accounting for 10-15% of lung cancer cases, characterized byrapid growth, and early metastasis. SCLC usually manifests as a large hilar mass with bulky mediastinal lymphadenopathy presenting clinically with chest pain, persistent cough, dyspnea, wheezing, hoarseness, hemoptysis, loss of appetite, weight loss, and neurological and endocrine paraneoplastic syndromes. SCLC is primarily reported in elderly people with a history of long-term tobacco exposure.